Lee Danner & Bass Inc. Makes New Investment in Medical Properties Trust, Inc. (NYSE:MPW)

Lee Danner & Bass Inc. bought a new position in Medical Properties Trust, Inc. (NYSE:MPW) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 22,640 shares of the real estate investment trust’s stock, valued at approximately $98,000.

Several other institutional investors and hedge funds also recently bought and sold shares of MPW. Lindbrook Capital LLC boosted its stake in shares of Medical Properties Trust by 112.1% in the first quarter. Lindbrook Capital LLC now owns 7,225 shares of the real estate investment trust’s stock worth $34,000 after acquiring an additional 3,819 shares during the period. Versant Capital Management Inc lifted its holdings in shares of Medical Properties Trust by 435.0% in the second quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 6,482 shares in the last quarter. Iron Horse Wealth Management LLC grew its stake in Medical Properties Trust by 166.7% during the second quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 5,000 shares in the last quarter. Future Financial Wealth Managment LLC bought a new stake in Medical Properties Trust in the 1st quarter valued at $38,000. Finally, Fidelis Capital Partners LLC bought a new position in shares of Medical Properties Trust during the 1st quarter valued at about $43,000. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

Medical Properties Trust Stock Up 1.5 %

Medical Properties Trust stock opened at $4.50 on Friday. Medical Properties Trust, Inc. has a 1-year low of $2.92 and a 1-year high of $7.40. The business has a fifty day moving average price of $4.63 and a 200-day moving average price of $4.59. The company has a debt-to-equity ratio of 1.51, a current ratio of 3.10 and a quick ratio of 3.10. The stock has a market capitalization of $2.70 billion, a price-to-earnings ratio of -2.02, a PEG ratio of 0.65 and a beta of 1.27.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.75). The business had revenue of $266.60 million during the quarter, compared to analyst estimates of $259.53 million. During the same period in the previous year, the company posted $0.48 earnings per share. The business’s quarterly revenue was down 21.0% on a year-over-year basis. Equities research analysts forecast that Medical Properties Trust, Inc. will post 0.88 EPS for the current fiscal year.

Medical Properties Trust Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 10th. Shareholders of record on Monday, September 9th will be given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 7.12%. The ex-dividend date is Monday, September 9th. Medical Properties Trust’s dividend payout ratio is presently -14.41%.

Analyst Upgrades and Downgrades

MPW has been the topic of a number of research analyst reports. Royal Bank of Canada reiterated a “sector perform” rating and issued a $5.00 target price on shares of Medical Properties Trust in a research report on Tuesday, May 14th. StockNews.com downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Saturday, May 18th. Truist Financial raised their price target on Medical Properties Trust from $4.50 to $5.00 and gave the stock a “hold” rating in a research report on Thursday, May 30th. Finally, BNP Paribas cut shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and cut their price objective for the company from $6.00 to $4.00 in a research report on Tuesday, July 2nd. Three investment analysts have rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $4.86.

Insider Buying and Selling at Medical Properties Trust

In other news, Director Elizabeth N. Pitman sold 10,025 shares of Medical Properties Trust stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $4.98, for a total transaction of $49,924.50. Following the completion of the sale, the director now directly owns 68,653 shares in the company, valued at $341,891.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Elizabeth N. Pitman sold 10,025 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $4.98, for a total value of $49,924.50. Following the sale, the director now owns 68,653 shares in the company, valued at $341,891.94. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director C Reynolds Thompson III sold 20,530 shares of the stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the completion of the sale, the director now owns 54,637 shares in the company, valued at approximately $239,310.06. The disclosure for this sale can be found here. 1.53% of the stock is currently owned by company insiders.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.